Introduction
additional ubiquitin molecules are added to the substrate. Multi-ubiquitinated proteins are then recognized by the Classical cadherins are complexed via their cytoplasmic 19S regulatory subunit of the proteasome and rapidly domains with three major catenins, termed α-, β-and γ-degraded into short peptides (reviewed in Jentsch, 1992) . catenin (plakoglobin). β-catenin and plakoglobin play a
Here we present results demonstrating that β-catenin is central role in the architecture of the cadherin-catenin regulated by the ubiquitin-proteasome pathway. We also complex, linking cadherins to α-catenin, which in turn show that ubiquitination of β-catenin is reduced in Wntmediates the anchorage of the cadherin complex to the expressing cells and completely abolished when the cortical actin cytoskeleton (reviewed in Kemler, 1993) .
GSK3β phosphorylation consensus motif in β-catenin Recently, many new interaction partners for β-catenin and/ is mutated. or plakoglobin have been identified, pointing to additional functions of β-catenin outside the cell adhesion complex (reviewed in Gumbiner, 1995; Huber et al., 1996a) .
Results
The structural homology of β-catenin and plakoglobin to the Drosophila Armadillo (Arm) protein, a component β-catenin is degraded by the proteasome pathway It is well established that lactacystin and the peptide of the Wingless (Wg) signaling pathway (McCrea et al., 1991; Butz et al., 1992) , suggested that these proteins aldehyde ALLN (N-acetyl-Leu-Leu-norleucinal, LLnL or included to demonstrate that the modified forms of β-catenin result from proteasome-specific inhibition, since ALLN also inhibits non-proteasomal proteases such as calpain inhibitor I) inhibit proteasome-mediated proteolysis, and that this leads to an accumulation of proteins calpains and cathepsins. ALLM (N-acetyl-Leu-Leumethional, LLM or calpain inhibitor II) is a structurally that are usually metabolized by this pathway (Coux et al., 1996) . In an initial set of experiments, the effect of ALLN related peptide aldehyde and a potent inhibitor of calpains and cathepsins, but it does not inhibit the proteolytic was tested on C57MG, LTK -and Neuro2A cells. Upon treatment with ALLN, all three cell lines clearly showed activity of proteasomes (Rock et al., 1994) . In contrast, the natural compound lactacystin is a highly specific higher molecular weight forms of β-catenin, while comparable modifications were not observed when the same cell inhibitor of proteasomal activity (Fenteany et al., 1995) . As can be seen in Figure 2A , only ALLN and lactacystin lysates were immunoblotted for p120 cas ( Figure 1A ). p120 cas , like β-catenin and plakoglobin, is a member of induced slower migrating forms of β-catenin and an accumulation of the protein. ALLM and two other diffusthe Arm repeat family, and it is also associated with the cadherin-catenin complex (Daniel and Reynolds, 1995) . ible protease inhibitors, pepstatin and leupeptin, as well as the phosphatase inhibitor vanadate, had no effect (Figure A similar analysis for plakoglobin in the same fibroblastic and neural cell lines was hampered by the low amount of 2A). From these results it is concluded that accumulation of post-translational modifications of β-catenins is induced plakoglobin in these cells (not shown).
Using the epithelial cell line A431, which expresses a only by proteasome-specific protease inhibitors. In timecourse experiments, it was found that the modification functional E-cadherin-catenin complex, the effect of ALLN on each component of the complex was investican already be observed 1 h after the addition of ALLN ( Figure 2B ). ALLN and lactacystin gave essentially gated. As can be seen in Figure 1B , in the presence of ALLN no changes in amount or mobility were observed identical results in all subsequent experiments. It was necessary to exclude that the post-translational for E-cadherin, α-catenin, or p120 cas . Here again, ALLN induced slower migrating, hence larger forms of β-catenin, modifications of β-catenin do not arise from hyperphosphorylation, since Arm is known to undergo Wg-dependent although the typical ladder of slower migrating bands was not as obvious as in fibroblastic cells. For the β-catenin alterations in its electrophoretic mobility due to changes in the phosphorylation pattern (Peifer et al., 1994a) . For homolog plakoglobin, higher molecular weight forms could also be detected in A431 cells in response to ALLN this, cell lysates of ALLN-treated or untreated cells, randomly labeled with radioactive phosphate, were treated ( Figure 1B) .
Thus it appears that β-catenin modifications are much with phosphatases and immunoblotted for β-catenin ( Figure 3 ). The autoradiograph in Figure 3B illustrates more prominent in non-epithelial cells. It is noteworthy that these cell types express considerable β-catenin mRNA that the phosphatase was active under these conditions. Immunoblot analysis of the same lysates with anti-β-but only little protein, suggesting that β-catenin is synthesized and degraded continuously. Interestingly, only comcatenin antibodies revealed that lambda phosphatase had no effect on the slower migrating forms of β-catenin ponents of the cadherin-catenin complex which could ALLN could be detected in C57MG, LTK -or Neuro2A s, p120 cas -Lact.; j, β-catenin ϩ Lact.; u, β-catenin -Lact.
cells (not shown).
Next we investigated whether lactacystin might increase the metabolic half-life of β-catenin. For this, C57MG cells were incubated with or without lactacystin for 4 h, metabolically labeled for 1 h and chased for the times indicated in Figure 4A . At each time point, β-catenin (and p120 cas as a control) was immunoprecipitated, using denaturing conditions to avoid any non-covalent proteinprotein interactions. The immunoprecipitates were separated by SDS-PAGE, processed for fluorography and subjected to quantitative measurements using a PhosphoImager ( Figure 4B ). In untreated cells, β-catenin had a rather short half-life of Ͻ60 min. In comparison, p120 cas appeared to be rather stable, with a half-life of 6-8 h, which was unchanged in the presence of inhibitors. Importantly, lactacystin increased the half-life of β-catenin by way. To demonstrate that the higher molecular weight forms of β-catenin indeed contain ubiquitin, a recently chelate chromatography. DNA coding for human ubiquitin tagged with six histidine residues at its N-terminus was developed assay for the detection of ubiquitinated proteins was employed (Treier et al., 1994) . This experimental transfected into Neuro2A cells. His-tagged cellular proteins were affinity purified and immunoblotted for β-system allows affinity purification of His-tagged ubiquitinsubstrate complexes under denaturing conditions by Ni 2ϩ -catenin. As can be seen in Figure 5 , only higher molecular acid residues S33, S37, T41 and S45 were all substituted by alanine, as reported (Yost et al., 1996) . Mutant β.5SD had aspartates at positions S29, S33, S37, T41 and S45; mutants β.K19R and β.K49R were single point mutations with a substitution of a lysine by an arginine, while mutant β.K19,49R contained both substitutions. Wild-type and mutant β-catenins carrying a C-terminal myc tag were transiently expressed in Neuro2A cells, treated with ALLN and immunoprecipitated with anti-myc antibodies ( Figure  7A ). Ubiquitination was abolished completely in mutants β.4SA and β.5SD. The negatively charged aspartate residues introduced in mutant β.S5D are apparently not able to trigger ubiquitination. In contrast, myc-tagged wild-type β-catenin (β.myc) and mutant forms β.K19R and β.K49K, as well as the double mutant β.K19,49R, all still became ubiquitinated in response to ALLN, although in the double mutant ubiquitination is slightly reduced ( Figure 7A ). It should be noted that overexpressed β- In conclusion, the mutational analysis clearly demonand re-probed with anti-β-catenin antibodies.
strated that the GSK3β consensus phosphorylation site in β-catenin is necessary for ubiquitination. This opened the possibility that an identical site in β-catenin is a target for weight forms of β-catenin were eluted from the Ni 2ϩ -chelate column. Little protein is detectable at the position both the Wnt signaling pathway and the ubiquitin-mediated degradation system. To test this possibility, NIH 3T3 cells of unmodified β-catenin, present in the whole cell lysate ( Figure 5 ). Cells transfected with hemagglutinin (HA)-and Wnt-1-transfected NIH 3T3 cells (3T3Wnt) generated by retroviral-mediated gene transfer were compared after tagged ubiquitin were included as a control. In another series of experiments, HA-tagged ubiquitin (and His6-ALLN treatment ( Figure 8A ). Expression of Wnt-1 in NIH 3T3 cells greatly reduced the ubiquitination of β-ubiquitin as a control) was transiently expressed in Neuro2A cells; immunoprecipitates were then collected catenin. In addition, expression of Wnt-1 led to an increased cytoplasmic stabilization of β-catenin, as monwith anti-β-catenin antibodies (or anti-p120 cas as a control), and subjected to immunoblot analysis with antibodies itored by binding studies with recombinant proteins ( Figure  8B ). For these studies, fusion proteins containing the directed against the HA epitope ( Figure 6A ). After stripping, the same blot was stained with anti-β-catenin antiglutathione-S-transferase (GST) tag and the full-length cytoplasmic domain of E-cadherin (ECT.884, amino acid bodies ( Figure 6B ). HA-positive higher molecular weight proteins were only detected in β-catenin immunoprecipiposition 737-884) or, as a control, a truncated version lacking the β-catenin-binding site (ECT.823, amino acid tates when the cells had been treated with ALLN. The differences in the intensity of staining of the HA-ubiquitinposition 737-823) were used in binding studies with cell lysates from NIH 3T3 cells or their Wnt-1 transfectant. ated β-catenin by the anti-HA antibody may be caused by the increased number of HA epitopes in the higher The ECT.884 fusion protein clearly interacted with uncomplexed β-catenin in Wnt-transfected cells, whereas no β-molecular weight forms. Thus, two independent experimental approaches demonstrate that inhibitors of catenin was precipitated in untransfected NIH 3T3 cells ( Figure 8B ). Upon ALLN treatment, ECT.884 interacted proteasome activity lead to an accumulation of multiubiquitinated β-catenin.
with ubiquitinated β-catenin in both cell types, indicating that ubiquitination does not interfere with binding of β-catenin to E-cadherin. Here again, in NIH 3T3 cells
The GSK3β consensus phosphorylation site in β-catenin is necessary for ubiquitination expressing Wnt-1, the relative amount of ubiquitinated β-catenin was considerably reduced. The faster migrating It has been shown previously that inhibition of ZW3/ GSK3β stabilizes Arm/β-catenin (Peifer et al., 1994a) and bands in Figure 8B are due to some degradation of β-catenin not seen in other cell types. that mutations in the GSK3β phosphorylation consensus sequence in β-catenin (amino acid positions 33-45) lead
The site necessary for ubiquitination in β-catenin is similar to a motif described in the N-terminus of IκB to an accumulation of mutant protein (Yost et al., 1996) . The results with the mutations in the GSK3β phosphoryla-(inhibitor of NFκB) which is required for the signaldependent degradation of IκB via the ubiquitin-protion consensus sequence in β-catenin stimulated experiments to test whether this region may also be important teasome pathway (Chen et al., 1995; DiDonato et al., 1996) . Alignment of the amino acid sequences of members for ubiquitination. To do this, several mutant β-catenin cDNAs were generated containing single or combinatorial of the β-catenin and IκB protein families reveals a conserved consensus motif ( Figure 7B ). Since this motif amino acid substitutions, as underlined in the amino acid sequence depicted in Figure 7A . In mutant β.4SA, amino is conserved in these proteins, it seems likely that plako- globin and Arm also become ubiquitinated; indeed, higher results in a cytoplasmic stabilization of β-catenin, namely in response to Wg/Wnt signaling. The stabilization of molecular weight modifications of plakoglobin have been found in response to ALLN ( Figure 1B ). Conversely, a hypophosphorylated Arm/β-catenin by the inhibition of ZW3/GSK3β after Wg/Wnt signaling represents one major similar consensus motif was not found in E-cadherin, α-catenin or p120 cas , all proteins which were not modified event in this pathway (Peifer et al., 1994a) . Mutations in the GSK3β consensus motif in β-catenin also lead to after ALLN treatment.
protein stability (Yost et al., 1996) . It is not known as yet whether β-catenin becomes phosphorylated within the
Discussion
GSK3β consensus motif itself, or whether this motif is only required for the phosphorylation of other residues in Our interest in the role of β-catenin in cell adhesion and signal transduction stimulated the analysis presented here the protein. In any case, it appears very likely that ZW3/ GSK3β uses Arm/β-catenin as a substrate. Another direct on the regulation of β-catenin stability. Previous work has established the central role of β-catenin in the E-cadherinsubstrate for GSK3β is APC, which must be phosphorylated for the increased binding of APC to β-catenin. catenin complex (Aberle et al., 1994) . A significant amount of β-catenin associates immediately after synthesis of EThis binding results in a reduced stability of β-catenin (Munemitsu et al., 1995; Rubinfeld et al., 1996) . At cadherin, most likely already co-translationally at the level of the endoplasmatic reticulum (Ozawa and Kemler, 1992) .
present, it appears that the intracellular pool of β-catenin is regulated by an active GSK3β which recognizes an It had been noted by us and others that many cadherinnegative cell lines accumulate a normal amount of β-APC-β-catenin complex. We show here that expression of WnT-1 in NIH 3T3 cells results in an increased catenin mRNA but only a very low level of β-catenin protein (Nagafuchi and Takeichi, 1989; cytoplasmic pool of β-catenin, in agreement with what occurs in C57MG cells (Papkoff et al., 1996) . More 1989). The introduction of E-cadherin into these cells clearly stabilized β-catenin protein, which had already importantly the expression of Wnt-1 reduced the amount of β-catenin available for ubiquitination. Our results indisuggested to us that in non-epithelial cells β-catenin might be synthesized and degraded continuously. The cate that GSK3β and the ubiquitination machinery use essentially the same site in β-catenin. We also provide the degradation of β-catenin by the ubiquitin-proteasome pathway reported here could, therefore, represent a general first evidence on a molecular link between the Wg/ Wnt signaling pathway and the ubiquitin-proteasome mechanism to regulate the turnover of β-catenin.
There is, however, another molecular mechanism which degradation pathway. Thus, in our present working model, DiDonato, 1996) . It has been shown that serine residues at positions 32 and 36 in IκBα are signal-dependently phosphorylated, this being a prerequisite for targeting the protein to the ubiquitin-proteasome pathway. We show here that mutations of the equivalent serine residues in β-catenin also abolish ubiquitination. The homology between the respective motifs in β-catenin and IκB suggests that the mechanism for degradation by the ubiquitin-proteasome pathway may be similar for both proteins.
Materials and methods

Chemicals and reagents
The calpain inhibitors ALLN and ALLM and other protease inhibitors were purchased from Sigma (Deisenhofen, Germany). Lactacystin was purchased from E.J.Corey (Harvard University, Cambridge, MA). ALLM, ALLN [10 mg/ml (25 mM) in ethanol] and lactacystin [4 mg/ml (10 mM) in water] were diluted 1:1000 into the cell culture medium to stimulate cells for 4-8 h. Fig. 8 . Ubiquitination of β-catenin is reduced in Wnt-expressing cells. (A) Upon ALLN treatment, the relative amount of ubiquitinated β-catenin was greatly reduced in NIH 3T3 cells expressing Wnt-1
Plasmids and constructs (3T3Wnt) as compared with untransfected NIH 3T3 cells.
The prokaryotic expression vector pGEXUCI encoding a GST fusion (B) Ubiquitinated β-catenin is able to bind to the cytoplasmic domain protein of the entire cytoplasmic domain of mouse E-cadherin of E-cadherin. Recombinant GST fusion protein ECT.884 containing (GSTECT884) has been described (Aberle et al., 1996) . GSTECT823 the entire cytoplasmic region of E-cadherin (ECT.823 lacking the was constructed by PCR using primers ECT.F.B (5ЈATAGGATCCA-β-catenin-binding site as a control) was used in binding studies with GAACGGTGGTCAAAGAG) and E2537r (5ЈACTGTCGACTCAGT-cell lysates from NIH 3T3 and Wnt-expressing NIH 3T3 cells.
CGCTGTCGGCTGCCTT). The PCR fragment was inserted into the ECT.884 efficiently precipitated β-catenin from 3T3Wnt but not from
BamHI-SalI sites of pGEX4T1 (Pharmacia, Freiburg, Germany). For all untransfected 3T3 cells, demonstrating that Wnt-1 increased the PCR reactions, Pwo polymerase (Boehringer, Mannheim, Germany), cytoplasmic pool of β-catenin. Upon ALLN treatment, the amount of which exhibits proofreading activity, was used. All PCR-derived conubiquitinated β-catenin is reduced in 3T3Wnt cells. The faster structs were sequenced using Sequenase 2.0 (US Biochemical Corp., migrating bands represent some degradation of β-catenin not seen in Cleveland, OH). other cell types. The asterisk denotes the position of non-ubiquitinated A eukaryotic expression vector for β-catenin carrying six histidine β-catenin.
residues at its C-terminus (pcDNA3β-His6) was constructed by PCR, using primers β1678 (5Јgcgggaacagggtgctattc) and β2440r (5Јtcag-gatcccaggtcagtatcaaac). The PCR fragment was cut with BamHI and the phosphorylation of β-catenin by GSK3β in the absence interaction is at present less well understood. APC is a epitope (Evan et al., 1985) flanked by a stop codon and restriction sites, multi-domain protein, and the interaction sites for β-were cloned into the prokaryotic vector pSP72 (Promega, Southampton, catenin represent only a small portion of the protein. Other UK) using BamHI (5Ј) and XhoI (3Ј). The BamHI site of pSP72myc tag interaction partners for APC are known, and still more was used to insert the BamHI fragment of pQE60βHis6 fusing the β-are likely to be identified (Kinzler and Vogelstein, 1996;  catenin cDNA missing a stop codon with the myc tag (pSPMMBCmyc tag, Mus musculus β-catenin). For expression in eukaryotic cells, a SacI- Peifer, 1996) . In the present context, it is tempting to XhoI fragment of pSPMMBCmyc tag containing the myc-tagged Cspeculate that APC may be involved in directing β-catenin terminus of β-catenin was inserted into a SacI-XhoI-digested pCS2 ϩ β to proteasomes.
(pCS2 ϩ MMBCmyc tag).
The GSK3β consensus motif in β-catenin is necessary
Site-directed mutagenesis was performed exactly as described (Aberle for ubiquitination. Since ubiquitination generally occurs et al., 1996) . Mutagenic primers were: K19R, TGACAGCA-GCGCGCCTGTCCGGCT (BssHII); K49R, AGGGTTGCCCCGGCCGon lysine residues (Hershko and Ciechanover, 1992), we CTCAGGGAA (EagI); S29D, GCCACTCAGGTCAGGAGCTGTGhave mutagenized lysine residues near the consensus site, TCGGTGGCACCATCATGAATTCCATCATCCAAGTAATCCTGCTbut this did not affect ubiquitination of β-catenin. We GCTGCC (EcoRI, BspHI); S33A, CTTGCCACTCAGCGCTGGcannot at present rule out that more distantly located AGCTGTGGCGGTTGCACCAGCATGGATTCCAGCATCCAAGTAlysine residues may serve as acceptor sites for ubiquitin. AGACTG (Eco47III) . Mutated N-termini of β-catenin were excised from pGEXMβX with SmaI (5Ј) and SacI (3Ј) and inserted into SmaIHowever, as noted above, there is an interesting homology
between the GSK3β consensus motif in β-catenin and a
The CMV-driven ubiquitin expression constructs pMT107 (His6-similar motif at the N-terminus of the inhibitor of NFκB ubiquitin) and pMT123 (HA-ubiquitin) have been described (Treier (IκB) which also mediates a phosphorylation-dependent et al., 1994) . and were kindly provided by D.Bohmann (EMBL, Heidelberg, Germany).
ubiquitination and degradation of IκBα (Chen et al., 1995;  Pear et al. (1993) . Briefly, DNA of the retroviral vector pLNCX.wnt1 (a kind gift of Jan Kitajewski), which harbors a full-length Wnt-1 cDNA under the References control of the CMV promotor (Miller and Rosman, 1989; Parkin et al., 1993) , was transfected into the packaging cell line Bosc23 using the Aberle,H., Butz,S., Stappert,J., Weissig,H., Kemler,R. and Hoschützky,H. calcium phosphate co-precipitation method. Supernatant containing viral (1994) Assembly of the cadherin-catenin complex in vitro with particles was harvested after 2-4 days and used to infect subconfluent recombinant proteins. J. Cell Sci., 107, 3655-3663. NIH 3T3 cells. Stably infected clones were selected with 1 mg/ml G418 Aberle,H., Schwartz,H., Hoschützky,H. and Kemler,R. (1996) Single and used as pools in subsequent experiments.
amino acid substitution in proteins of the armadillo gene family Cells grown to 80% confluency were washed twice with phosphateabolish their binding to α-catenin. J. Biol. Chem., 271, 1520-1526. buffered saline (PBS) and lysed in 1 ml of PSK buffer [10 mM PIPES, Behrens,J., Vonkries,J.P., Kuhl,M., Bruhn,L., Wedlich,D., Grosschedl,R. pH 6.8, 300 mM sucrose, 100 mM KCl, 2 mM MgCl 2 , 4 mM EGTA, and Birchmeier,W. (1996) Functional interaction of β-catenin with the 1 mM NaF, 1 mM sodium vanadate, 0.25% (v/v) Triton X-100 (TXtranscription factor lef-1. Nature, 382, 638-642. 100), 10 μg/ml leupeptin, 10 μg/ml phenylmethylsulfonyl fluoride Butz,S. and Kemler,R. (1994) Distinct cadherin-catenin complexes in (PMSF) and 0.1 μg/ml α 2 -macroglobulin]. Cell lysates were subjected to Ca 2ϩ -dependent cell-cell adhesion. FEBS Lett., 355, [195] [196] [197] [198] [199] [200] . immunoprecipitation experiments as described (Hoschützky et al., 1994 et al., 1996) . specific amino-terminal threonine modification by lactacystin. Science, Purification of His-tagged ubiquitin transiently expressed in Neuro2A 268, 726-731. cells was done following the method of Treier et al. (1994) with the Gumbiner,B.M. (1995) Signal transduction by β-catenin. Curr. Opin. following modifications. Cells were lysed with 1 ml of GTN buffer per Cell Biol., 7, 634-640. 100 mm dish (6 M guanidinium-HCl, 20 mM Tris-HCl, pH 8.0, 200 Hershko,A. and Ciechanover,A. (1992) The ubiquitin system for protein mM NaCl, 10 mM imidazole, 0.1% TX-100). Ni 2ϩ -NTA-agarose beads degradation. Annu. Rev. Biochem., 61, 761-807. (Qiagen) (50 μl, 50% slurry) were successively washed with the following solutions (pH 7.5-8.0): 1 ml of GTN buffer; 1 ml of 8 M urea, 20 mM Hoschützky,H., Aberle,H. and Kemler,R. (1994) β-Catenin mediates the Tris-HCl, 200 mM NaCl, 0.1% TX-100; 1 ml of 8 M urea, 20 mM interaction of the cadherin-catenin complex with epidermal growth Tris-HCl, 1 M NaCl, 0.1% TX-100; 1 ml of 4 M urea, 20 mM Trisfactor receptor. J. Cell Biol., 127, 1375-1380. HCl, 200 mM NaCl, 0.1% TX-100; 1 ml of 1 M urea, 20 mM TrisHuber,O., Bierkamp,C. and Kemler,R. (1996a) Cadherins and catenins HCl, 200 mM NaCl, 0.1% TX-100; and 1 ml of 20 mM 200 in development. 
